Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curevac N.V. (NQ: CVAC )

3.670 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,629
Open 3.670
Bid (Size) 3.630 (12)
Ask (Size) 3.690 (10)
Prev. Close 3.670
Today's Range 3.670 - 3.670
52wk Range 2.215 - 10.14
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q1 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
Via ACCESSWIRE

Performance

YTD
-12.41%
-12.41%
1 Month
+12.58%
+12.58%
3 Month
+45.06%
+45.06%
6 Month
-3.42%
-3.42%
1 Year
-59.40%
-59.40%

More News

Read More
Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know
Via InvestorPlace
Why Is DouYu (DOYU) Stock Up 44% Today?
Via InvestorPlace
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery
Via InvestorPlace
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Via ACCESSWIRE
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Via ACCESSWIRE
DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million
Via InvestorPlace
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
Via InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Via Benzinga
Exposures COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
Via ACCESSWIRE
CureVac Announces Voting Results of General Meeting
Via ACCESSWIRE
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Via Benzinga
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
Via ACCESSWIRE
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
Via Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
3 Stocks to Purge ASAP Before They’re Pulled off Life Support
Via InvestorPlace
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.